Bionano Genomics (BNGO) Research & Development (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Research & Development for 9 consecutive years, with $3.2 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 7.05% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Dec 2025, down 54.14% year-over-year, with the annual reading at $11.4 million for FY2025, 54.14% down from the prior year.
- Research & Development hit $3.2 million in Q4 2025 for Bionano Genomics, up from $2.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $14.6 million in Q2 2023 to a low of $2.4 million in Q1 2025.
- Historically, Research & Development has averaged $8.1 million across 5 years, with a median of $8.0 million in 2021.
- Biggest five-year swings in Research & Development: surged 293.09% in 2022 and later tumbled 75.76% in 2025.
- Year by year, Research & Development stood at $9.2 million in 2021, then soared by 52.05% to $14.0 million in 2022, then decreased by 16.49% to $11.7 million in 2023, then plummeted by 70.31% to $3.5 million in 2024, then decreased by 7.05% to $3.2 million in 2025.
- Business Quant data shows Research & Development for BNGO at $3.2 million in Q4 2025, $2.8 million in Q3 2025, and $2.9 million in Q2 2025.